toxylact: a07bc02 kaolin

The first professional lActological database in the word

Kaolin (ATC A07BC02) is a non‑absorbed intestinal adsorbent and demulcent clay used in some antidiarrheal and gut‑protective preparations, with zero gastrointestinal bioavailability and a very low expected risk during breastfeeding.atcddd.fhi+3

ATC A07BC02 overview

ATC code A07BC02 designates kaolin within the subgroup “Other intestinal adsorbents” (A07BC), part of the intestinal adsorbents class A07B among antidiarrheals. In clinical practice kaolin is most often used together with pectin in kaolin‑pectin suspensions for symptomatic treatment of acute diarrhea.atcddd.fhi+5

Pharmacology and mechanism

Kaolin (hydrated aluminum silicate, “white clay”) acts as a chemically inert adsorbent that binds bacteria, toxins, and water in the intestinal lumen and forms a protective coating on inflamed mucosa. This demulcent and adsorptive effect can modestly thicken stools and reduce irritation, although controlled studies in children show limited impact on stool frequency or total stool output.sciencedirect+5

Therapeutic indications

Within A07BC02, kaolin—usually as kaolin‑pectin liquid—is indicated as a short‑term symptomatic treatment for acute, non‑specific diarrhea and as a gastrointestinal protectant. These products are commonly available over the counter and are meant to be used alongside, not instead of, oral rehydration and etiological evaluation when indicated.drugs+2

Pharmacokinetics relevant to lactation

Kaolin has “zero bioavailability”: it is not absorbed from the maternal gastrointestinal tract and is eliminated unchanged in the feces. Because it does not enter the maternal circulation, kaolin is not expected to be transferred into human milk in any meaningful amount.ams.usda+1

Maternal safety profile

At usual oral doses for diarrhea, kaolin is generally well tolerated; constipation is the most common side effect, particularly with high or frequent dosing. Chronic or excessive intake (well beyond antidiarrheal doses) has been associated with intestinal obstruction, iron‑deficiency anemia, and possible heavy‑metal exposure in geophagia, but these scenarios differ markedly from short‑term medicinal use.webmd+2

Lactation safety assessment

Lactation‑specific references classify kaolin as compatible with breastfeeding and “not risky for breastfeeding or infant,” explicitly citing its lack of absorption and absence from breast milk. General reviews of gastrointestinal drugs in breastfeeding also regard short‑term use of non‑absorbed intestinal adsorbents as very low risk, especially compared with systemically active alternatives.pubmed.ncbi.nlm.nih+1

Potential effects on the breastfed infant

Because kaolin is not systemically absorbed by the mother, direct exposure of the infant via breast milk is expected to be negligible, and kaolin‑related toxicity or interference with infant nutrient absorption is not anticipated. Any risk to the infant is much more likely to arise from the underlying maternal illness (for example viral or bacterial gastroenteritis) or from co‑formulated active ingredients (such as opiates in older combination products), which require separate evaluation.pubmed.ncbi.nlm.nih+3

Practical use in breastfeeding women

For breastfeeding mothers with mild, self‑limited diarrhea, first‑line management remains oral rehydration and dietary adjustment, with contemporary guidance often favoring loperamide when an antidiarrheal drug is needed. Where kaolin‑containing products (commonly kaolin‑pectin) are used, they can generally be taken during breastfeeding without altering feeding schedules, provided dosing is short‑term and label directions are followed, while both mother and infant are monitored for persistence or worsening of symptoms.pubmed.ncbi.nlm.nih+5

Role among intestinal adsorbents

Compared with other intestinal adsorbents, kaolin combines an excellent toxico‑lactological profile with modest symptomatic benefit and has largely been supplanted by more effective agents in evidence‑based guidelines. Its local, non‑absorbed nature, however, makes it a very low‑risk option in breastfeeding when used appropriately and when alternatives are unavailable or unsuitable.pubmed.ncbi.nlm.nih+4


Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.